{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:46:19Z","timestamp":1761630379535},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1982,2,1]],"date-time":"1982-02-01T00:00:00Z","timestamp":381369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Res. Exp. Med."],"published-print":{"date-parts":[[1982,2]]},"DOI":"10.1007\/bf01852236","type":"journal-article","created":{"date-parts":[[2005,6,29]],"date-time":"2005-06-29T03:09:24Z","timestamp":1120014564000},"page":"95-98","source":"Crossref","is-referenced-by-count":5,"title":["Bezafibrate: Lack of effect on creatinine excretion and muscular proteins"],"prefix":"10.1007","volume":"180","author":[{"given":"D. P.","family":"Mertz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01852236_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-510X(79)90149-7","volume":"42","author":"N Abourizk","year":"1979","unstructured":"Abourizk N, Khalil BA, Bahuth N, Afifi AK (1979) Clofibrate-induced muscular syndrome. Report of a case with clinical, electromyographic, and pathologic observations. J Neurol Sci 42:1\u20139","journal-title":"J Neurol Sci"},{"key":"BF01852236_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF01711180","volume":"59","author":"H Heidemann","year":"1981","unstructured":"Heidemann H, Bock KD, Kreuzfelder E (1981) Rhabdomyolysis with acute renal failure due to bezafibrate. Klin Wochenschr 59:413\u2013414","journal-title":"Klin Wochenschr"},{"key":"BF01852236_CR3","first-page":"137","volume-title":"Diet and drugs in atherosclerosis","author":"PD Lang","year":"1980","unstructured":"Lang PD, Holler HD, Vollmar J (1980) Tolerance of 1 year's treatment with bezafibrate in patients with hyperlipoproteinaemia. In: Noseda G, Lewis B, Paoletti R (eds) Diet and drugs in atherosclerosis. Raven Press, New York, pp 137\u2013142"},{"key":"BF01852236_CR4","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJM196810172791604","volume":"279","author":"T Langer","year":"1968","unstructured":"Langer T, Levy RI (1968) Acute muscular syndrome associated with administration of clofibrate. New Engl J Med 279:856\u2013858","journal-title":"New Engl J Med"},{"key":"BF01852236_CR5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0021-9150(78)90137-5","volume":"31","author":"AG Olsson","year":"1978","unstructured":"Olsson AG, Lang PD (1978) Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinemia. Atherosclerosis 31:421\u2013428","journal-title":"Atherosclerosis"},{"key":"BF01852236_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1172\/JCI109476","volume":"64","author":"HS Paul","year":"1979","unstructured":"Paul HS, Adibi SA (1979) Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. J Clin Invest 64:405\u2013412","journal-title":"J Clin Invest"},{"key":"BF01852236_CR7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1172\/JCI109791","volume":"65","author":"HS Paul","year":"1980","unstructured":"Paul HS, Adibi SA (1980) Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats. J Clin Invest 65:1285\u20131293","journal-title":"J Clin Invest"},{"key":"BF01852236_CR8","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(75)90613-3","volume":"II","author":"AM Pierides","year":"1975","unstructured":"Pierides AM, Alvarez-Ude F, Kerr DNS (1975) Clofibrate-induced muscle damage in patients with chronic renal failure. Lancet II:1279\u20131282","journal-title":"Lancet"},{"key":"BF01852236_CR9","first-page":"806","volume":"52","author":"N Pokroy","year":"1977","unstructured":"Pokroy N, Ress S, Gregory MC (1977) Clofibrate-induced complications in renal disease. A case report. S Afr Med J 52:806\u2013808","journal-title":"S Afr Med J"},{"key":"BF01852236_CR10","first-page":"942","volume":"296","author":"AGH Smals","year":"1977","unstructured":"Smals AGH, Beex LVAM, Kloppenborg PWC (1977) Clofibrate-induced muscle damage with myoglobinuria and cardiomyopathy. New Engl J Med 296:942","journal-title":"New Engl J Med"}],"container-title":["Research in Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01852236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01852236\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01852236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T21:21:59Z","timestamp":1557436919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01852236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,2]]}},"alternative-id":["BF01852236"],"URL":"https:\/\/doi.org\/10.1007\/bf01852236","relation":{},"ISSN":["0300-9130","1433-8580"],"issn-type":[{"value":"0300-9130","type":"print"},{"value":"1433-8580","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,2]]}}}